Jerel Davis

Chairman of Board of Directors at Ventus Therapeutics

Jerel is a Managing Director at Versant Venture Management, LLC, a healthcare investment firm. He has played a critical role in Versant’s company creation strategies and has been heavily involved in a number of public and private biotech companies such as Crispr (CRSP), BlueRock (sale), Repare (RPTX), Akero (AKRO), Graphite (GRPH), Chinook (KDKY), Inception 4 (sale), Inception 5 (sale), Northern (sale), Rayze, Ventus, Turnstone, and Tentarix. Prior to joining Versant, Jerel was an Associate Principal at McKinsey and Company where he advised healthcare corporations in pharmaceuticals, biotechnology, medical device and molecular diagnostics. He has worked in a number of healthcare markets globally including the U.S., Europe, China, and Russia. Jerel earned his doctorate from Stanford University, where he also completed post-doctoral research.

Location

Vancouver, Canada

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Ventus Therapeutics

1 followers

Ventus Therapeutics is advancing the next frontier for structure-based drug design to navigate elusive targets, in Montreal and Waltham, MA.


Headquarters

Montréal, Canada

Employees

11-50

Links